Hao-Yang Mi1,2,3, Xin Jing1,2,3, James A Thomsom4, Lih-Sheng Turng1,3. 1. Wisconsin Institute for Discovery, University of Wisconsin-Madison, WI, 53715, USA. 2. Department of Industrial Equipment and Control Engineering, South China University of Technology, Guangzhou, 510640, China. 3. Department of Mechanical Engineering, University of Wisconsin-Madison, WI, 53706, USA. 4. Morgridge Institute for Research, University of Wisconsin-Madison, WI, 53715, USA.
Abstract
When used as small-diameter vascular grafts (SDVGs), synthetic biomedical materials like polytetrafluoroethylene (PTFE) may induce thrombosis and intimal hyperplasia due to the lack of an endothelial cell layer. Modification of the PTFE in an aqueous solution is difficult because of its hydrophobicity. Herein, aiming to simultaneously promote endothelial cell affinity and antithrombogenicity, a mussel-inspired modification approach was employed to enable the grafting of various bioactive molecules like RGD and heparin. This approach involves a series of pragmatic steps including oxygen plasma treatment, dopamine (DA) coating, polyethylenimine (PEI) grafting, and RGD or RGD/heparin immobilization. Successful modification in each step was verified via Fourier transform infrared (FTIR) spectroscopy and X-ray photoelectron spectroscopy (XPS). Plasma treatment increased the hydrophilicity of PTFE, thereby allowing it to be efficiently coated with dopamine. Grafting of dopamine, RGD, and heparin led to an increase in surface roughness and a decrease in water contact angle due to increased surface energy. Platelet adhesion increased after dopamine and RGD modification, but it dramatically decreased when heparin was introduced. All of these modifications, especially the incorporation of RGD, showed favorable effects on endothelial cell attachment, viability, and proliferation. Due to strong cell-substrate interactions between endothelial cells and RGD, the RGD/heparin-grafted PTFE demonstrated high endothelial cell affinity. This facile modification method is highly suitable for all hydrophobic surfaces and provides a promising technique for SDVG modification to stimulate fast endothelialization and effective antithrombosis.
When used as small-diameten class="Chemical">r vaspan> class="Chemical">cular grafts (SDVGs), synthetic biomedical materials like polytetrafluoroethylene (PTFE) may induce thrombosis and intimal hyperplasia due to the lack of an endothelial cell layer. Modification of the PTFE in an aqueous solution is difficult because of its hydrophobicity. Herein, aiming to simultaneously promote endothelial cell affinity and antithrombogenicity, a mussel-inspired modification approach was employed to enable the grafting of various bioactive molecules like RGD and heparin. This approach involves a series of pragmatic steps including oxygen plasma treatment, dopamine (DA) coating, polyethylenimine (PEI) grafting, and RGD orRGD/heparin immobilization. Successful modification in each step was verified via Fourier transform infrared (FTIR) spectroscopy and X-ray photoelectron spectroscopy (XPS). Plasma treatment increased the hydrophilicity of PTFE, thereby allowing it to be efficiently coated with dopamine. Grafting of dopamine, RGD, and heparin led to an increase in surface roughness and a decrease in watercontact angle due to increased surface energy. Platelet adhesion increased afterdopamine and RGD modification, but it dramatically decreased when heparin was introduced. All of these modifications, especially the incorporation of RGD, showed favorable effects on endothelial cell attachment, viability, and proliferation. Due to strong cell-substrate interactions between endothelial cells and RGD, the RGD/heparin-grafted PTFE demonstrated high endothelial cell affinity. This facile modification method is highly suitable for all hydrophobic surfaces and provides a promising technique for SDVG modification to stimulate fast endothelialization and effective antithrombosis.
Authors: Radosław Mrówczyński; L Emerson Coy; Błażej Scheibe; Tomasz Czechowski; Maria Augustyniak-Jabłokow; Stefan Jurga; Krzysztof Tadyszak Journal: J Phys Chem B Date: 2015-07-29 Impact factor: 2.991
Authors: Kevin A Rocco; Mark W Maxfield; Cameron A Best; Ethan W Dean; Christopher K Breuer Journal: Tissue Eng Part B Rev Date: 2014-06-18 Impact factor: 6.389
Authors: Xin Jing; Hao-Yang Mi; Max R Salick; Travis M Cordie; Xiang-Fang Peng; Lih-Sheng Turng Journal: Mater Sci Eng C Mater Biol Appl Date: 2014-12-18 Impact factor: 7.328
Authors: Elena Mavropoulos; Moema Hausen; Andrea M Costa; Gutemberg Alves; Alexandre Mello; C A Ospina; M Mir; José M Granjeiro; Alexandre M Rossi Journal: J Mater Sci Mater Med Date: 2013-03-14 Impact factor: 3.896
Authors: Vineeth M Vijayan; Bernabe S Tucker; Patrick T J Hwang; Pratheek S Bobba; Ho-Wook Jun; Shane A Catledge; Yogesh K Vohra; Vinoy Thomas Journal: J Mater Chem B Date: 2020-04-08 Impact factor: 6.331
Authors: Chenglong Yu; Huaguang Yang; Lu Wang; James A Thomson; Lih-Sheng Turng; Guoping Guan Journal: Mater Sci Eng C Mater Biol Appl Date: 2021-07-09